C9 - complement C9 Gene

Also Known as C9D; ARMD15

Species: Homo sapiens

Gene Type: protein coding
Gene ID: 735

About C9

Cytogenetic location: 5p13.1 Genomic coordinates (GRCh38): 5:39,284,140-39,364,495 (from NCBI)

This gene has 7 transcripts (splice variants), 190 orthologues, 39 paralogues and is associated with 4 phenotypes. Restricted expression toward liver (RPKM 365.0).

Summary

This gene encodes the final component of the Complement System. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on Bacterial membranes to form a pore, permitting disruption of Bacterial membrane organization. Mutations in this gene cause component C9 deficiency. [provided by RefSeq, Feb 2009]

C9 Products (1)

mRNA Protein Name
NM_001737.5 NP_001728.1 complement component C9 preproprotein

Gene Ontology

  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence Verweise Source
enables protein binding IPI
IPI: Inferred from physical interaction
28514442 GOA
Biological Process GO Annotation Evidence Verweise Source
involved in cell killing IDA
IDA: Inferred from direct assay
26841934 GOA
involved in protein homooligomerization IDA
IDA: Inferred from direct assay
26841934 GOA
Cellular Component GO Annotation Evidence Verweise Source
located in extracellular space IDA
IDA: Inferred from direct assay
22832194 GOA
part of membrane attack complex IDA
IDA: Inferred from direct assay
22832194 GOA
part of membrane attack complex IPI
IPI: Inferred from physical interaction
30552328 GOA
located in plasma membrane IDA
IDA: Inferred from direct assay
26841934 GOA
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

C9 Protein Structure

TSP_1

TSP_1: Thrombospondin type 1 domain (46 - 94)

Ldl_recept_a

Ldl_recept_a: Low-density lipoprotein receptor domain class A (100 - 134)

MACPF

MACPF: MAC/Perforin domain (272 - 501)

  • 0
  • 100
  • 200
  • 300
  • 400
  • 500
  • 559 a.a.
Protein Preferred Names Protein Names

complement component C9

  • complement component 9

C9 Protein-protein interaction Information

Type
Protein Name Protein ID Interactor Interactor Species Interactor ID Detection Method Verweise
Intra
C9 P02748 APOE Homo sapiens P02649
Anti Tag CoIP
33961781
Intra
C9 P02748 APOE Homo sapiens P02649
Anti Tag CoIP
28514442
Cross: Cross-species interaction Intra: Intraspecies interaction

Related Diseases

Diseases Alias
Complement Component 9 Deficiency

  • C9 Deficiency

  • C9D

  • C9 Deficiency With Dermatomyositis
Macular Degeneration, Age-Related, 15

  • Age Related Macular Degeneration 15

  • ARMD15

  • Macular Degeneration, Age-Related, 15, Susceptibility To

  • Macular Degeneration, Age-Related, Type 15
Immunodeficiency Due To A Late Component Of Complement Deficiency

  • Immunodeficiency Due To C5 To C9 Component Complement Deficiency

  • Terminal Complement Pathway Deficiency
Meningococcal Meningitis

  • Meningitis, Meningococcal

  • Meningitis Meningococcal

  • Epidemic Meningitis

  • Meningitis Due To Neisseria Meningitidis

  • Meningococcal Meninges Infection

  • Meningococcal Meningeal Infection

  • Meningococcal Cerebrospinal Inflammation

  • Chronic Meningococcal Arachnoiditis

  • Meningococcal Arachnoiditis

  • Diplococcal Spinal Meningitis

  • Diplococcal Meningitis

  • Meningococcal Cerebrospinal Fever

  • Meningococcal Cerebrospinal Infection

  • Meningococcal Spinal Meningitis
Immunoglobulin Heavy-And-Light Chain

  • Ah/Al Amyloidosis

  • Ig Heavy-And-Light-Chain Amyloidosis
Eye Disease

  • Eye Diseases

  • Abnormality Of The Eye

  • Toxoplasma Oculopathy
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (17)
Art. -Nr. Produktname Wirkung
Reinheit Rare Diseases
HY-17356 Fenofibrate 99.97% Yes
HY-B0113 Omeprazole Inhibitor 99.96% Yes
HY-N6972 Cepharanthine 99.87% Yes
HY-B1218 Sulfaphenazole Inhibitor 99.85% Unkown
HY-B0258 Gemfibrozil 99.91% Yes
HY-11103 Sitaxsentan sodium 98.83% Unkown
HY-100386 Ticlopidine Inhibitor 99.74% Unkown
HY-B0113A Omeprazole sodium Inhibitor 99.10% Yes
HY-13463 Avatrombopag Agonist 99.83% Yes
HY-B0153A Ticlopidine hydrochloride Inhibitor 99.99% Unkown
HY-13463A Avatrombopag maleate 99.99% Yes
HY-B0113R Omeprazole (Standard) Inhibitor 99.86% Unkown
HY-13463B Avatrombopag hydrochloride Agonist 97.05% Yes
HY-B1376 Methsuximide 99.68% Unkown
HY-76520 Sitaxsentan 98.96% Unkown
HY-109546 Omeprazole magnesium Inhibitor / Unkown
HY-111654 Diflucortolone / Unkown

Clinical Phase

Bioactive Molecules (10)
Art. -Nr. Produktname Wirkung
Reinheit Phase
HY-132581 Tadnersen Inhibitor 99.30% Phase 3
HY-121872 DP-b99 Inhibitor 95.0% Phase 3
HY-N1201 Apigenin 99.22% Phase 2
HY-13024 Rebastinib 99.84% Phase 2
HY-106379 Lurosetron Antagonist / Phase 2
HY-19397 BMS-223131 / Phase 2
HY-15565 APD668 99.73% Phase 1
HY-15566 APD597 Agonist 99.97% Phase 1
HY-114415 AWZ1066S Inhibitor 98.64% Phase 1
HY-12946A BI 653048 phosphate Inhibitor / Phase 1

Pre-clinical Phase

Bioactive Molecules (248)
Art. -Nr. Produktname
Wirkung
Reinheit
Rare Diseases
HY-N0904 Ginsenoside C-K Inhibitor 99.93% Unkown
HY-N0893 Tetrahydrocurcumin 98.96% Unkown
HY-15550 4'-Hydroxy diclofenac 99.70% Unkown
HY-N0043 Ginsenoside Rd Inhibitor 99.88% Unkown
HY-15550S 4'-Hydroxy diclofenac-d4 98.92% Unkown
HY-W013268 (S)-(+)-N-3-Benzylnirvanol Inhibitor 99.76% Unkown
HY-103661 BI-6C9 Inhibitor 98.47% Unkown
HY-N0762 Isobavachin 99.88% Unkown
HY-N1446S Oleic acid-13C 99.99% Unkown
HY-D1422 ER Tracker Yellow 96.91% Unkown
HY-114759 MS-PPOH Inhibitor 99.05% Unkown
HY-117026 LKY-047 Inhibitor 99.94% Unkown
HY-153898 rTRD01 Ligand 99.10% Unkown
HY-100738 Ubiquitin Isopeptidase Inhibitor I, G5 Inducer 98.0% Unkown
HY-N0473S3 L-Tyrosine-13C9 99.81% Unkown
HY-N0215S10 L-Phenylalanine-13C9 Antagonist 98.09% Unkown
HY-100641 4-Hydroxytolbutamide 99.69% Unkown
HY-N1201R Apigenin (Standard) 98.82% Unkown
HY-170538 SNT-5382 Inhibitor 99.96% Unkown
HY-18063 ML252 Inhibitor 99.9% Unkown
HY-117389 Homocarbonyltopsentin 99.82% Unkown
HY-W140827 Boc-C9-Br / Unkown
HY-N0215S11 L-Phenylalanine-13C9,15N Antagonist 99.42% Unkown
HY-N0920 Dihydrokavain Inhibitor 99.94% Unkown
HY-B0158S7 Cytidine-13C9 Chemical 98.69% Unkown
HY-W013175S2 Uridine 5'-monophosphate-13C9,15N2 disodium Activator 99.77% Unkown
HY-139345 (S,R,S)-AHPC-CO-C9-acid Chemical 95.00% Unkown
HY-N1050 Zederone Inhibitor 99.61% Unkown
HY-100641S 4-Hydroxytolbutamide-d9 99.29% Unkown
HY-132581A Tadnersen sodium Inhibitor 99.30% Unkown
HY-42034 Hydroquinine 99.87% Unkown
HY-W751165 Uridine-13C9,15N2 98.88% Unkown
HY-113359AS2 Uridine 5'-diphosphate-13C9,15N2 dilithium Agonist 99.5% Unkown
HY-125818S3 Cytidine-5'-triphosphate-13C9 dilithium 98.02% Unkown
HY-14362 GSK-25 Inhibitor 98.33% Unkown
HY-148822 Nampt activator-2 Activator 98.79% Unkown
HY-N0911 Rehmannioside A 99.95% Unkown
HY-W108995 Boc-C9-COOH ≥97.0% Unkown
HY-128859 EMT inhibitor-2 Inhibitor 98.83% Unkown
HY-B1449S11 Uridine-13C9 96.8% Unkown
HY-116862 Dibenzylfluorescein 99.54% Unkown
HY-B0113S Omeprazole-d3 Inhibitor 98.99% Unkown
HY-147294 Nivasorexant 99.74% Unkown
HY-144652 IDO1-IN-19 Inhibitor 98.82% Unkown
HY-17356R Fenofibrate (Standard) 99.92% Unkown
HY-B0258R Gemfibrozil (Standard) 99.82% Unkown
HY-N7057S3 Nonanoic acid-d2 98.0% Unkown
HY-W009162S5 Cytidine 5′-monophosphate-13C9,15N3 dilithium 99.80% Unkown
HY-N11222 Nonanoylcarnitine 99.87% Unkown
HY-W587878 Thujopsene 86.31% Unkown
HY-12946 BI 653048 Inhibitor 99.84% Unkown
HY-17356S Fenofibrate-d6 99.70% Unkown
HY-B0113S3 Omeprazole-13C,d3 Inhibitor 98.00% Unkown
HY-N1201S Apigenin-d5 98.90% Unkown
HY-N5132 (-)-Fenchone 98.0% Unkown
HY-Y0123S L-Tyrosine-13C9,15N 98.0% Unkown
HY-107372S2 Uridine triphosphate-13C9 dilithium 99.33% Unkown
HY-161943 NEU3-IN-1 98.74% Unkown
HY-170510 GB2095 Inhibitor 98.92% Unkown
HY-D0184S3 2'-Deoxycytidine-13C9,15N3 98.74% Unkown
HY-N8382 Chalepensin Inhibitor 98.98% Unkown
HY-15550S1 4'-Hydroxy diclofenac-13C6 99.21% Unkown
HY-W018801 5-Nitroisoquinoline 99.38% Unkown
HY-A0070AS1 Liothyronine-13C9,15N / Unkown
HY-W009216S1 2'-Deoxycytidine-5'-monophosphate-13C9,15N3 dilithium 99.8% Unkown
HY-B0258S Gemfibrozil-d6 98.71% Unkown
HY-101399S γ-Glu-(Phe-13C9,15N) / Unkown
HY-107372S Uridine triphosphate-13C9,15N2 sodium / Unkown
HY-124352 2-Nonyl-3-hydroxy-4-quinolone 98.0% Unkown
HY-131495 (S)-6-O-Desmethylnaproxen Inhibitor 95.73% Unkown
HY-138527 Thiol-C9-PEG4 99.06% Unkown
HY-155265 Pomalidomide-5-C9-NH2 hydrochloride 98.68% Unkown
HY-156159 Thalidomide-NH-C9-NH2 hydrochloride Inducer 99.85% Unkown
HY-U00048 Bucolome Inhibitor 98.93% Unkown
HY-W141374 CB096 98.72% Unkown
HY-Z2667 (R)-Esomeprazole Modulator 96.41% Unkown
HY-101399SA γ-Glu-(Phe-13C9,15N) TFA 99.74% Unkown
HY-117160 4-trans-Hydroxy-glibenclamide Inhibitor 99.0% Unkown
HY-132581E Scrambled Tadnersen Control / Unkown
HY-159191S VQPGQN(Phe-13C9,15N)HMFTKEKLEEVIKDI TFA 95.41% Unkown
HY-18063A ML252 hydrochloride Inhibitor 98.5% Unkown
HY-B0158S5 Cytidine-13C9,15N3 98.9% Unkown
HY-N6023 Thermopsoside 98.0% Unkown
HY-172177 ROCK/HDAC-IN-2 / Unkown
HY-13024A Rebastinib tosylate / Unkown
HY-135390 Hydroxy desmethyl Bosentan / Unkown
HY-100386S Ticlopidine-d4 Inhibitor / Unkown
HY-100641S1 4-Hydroxytolbutamide-d9-1 / Unkown
HY-101400S2 Deoxycytidine triphosphate-13C9,15N3 dilithium Activator / Unkown
HY-101400S4 Deoxycytidine triphosphate-13C9 dilithium Activator / Unkown
HY-101981S3 Uridine 5'-monophosphate-13C9,15N2 dilithium Activator / Unkown
HY-101981S4 Uridine 5'-monophosphate-13C9 dilithium Activator / Unkown
HY-105408A Fandosentan potassium / Unkown
HY-10575 MK-5596 / Unkown
HY-105828 Sulfamethylphenazole Inhibitor / Unkown
HY-111906 SCYX-6759 Inhibitor / Unkown
HY-113359AS1 Uridine 5'-diphosphate-13C9 dilithium Agonist / Unkown
HY-113400S1 Cytidine diphosphate-13C9 dilithium / Unkown
HY-113400S2 Cytidine diphosphate-13C9,15N3 dilithium 99.7% Unkown
HY-113887 Prostaglandin F1β Agonist / Unkown
HY-113887A 11β-Prostaglandin F1β Control / Unkown
HY-116095 CypD-IN-5 Inhibitor / Unkown
HY-116601 6-Hydroxywarfarin 99.87% Unkown
HY-116811 AZ-11665362 / Unkown
HY-119781 Kaitocephalin Antagonist / Unkown
HY-119996 AR-C141990 Inhibitor / Unkown
HY-121698 GW694481 Inhibitor / Unkown
HY-122163 MK-3901 / Unkown
HY-132581C Scrambled Tadnersen sodium Control / Unkown
HY-13463BS Avatrombopag-d8 hydrochloride Agonist / Unkown
HY-138517 Thiol-C9-PEG7 / Unkown
HY-138526 Thiol-C9-PEG4-acid / Unkown
HY-138528 Thiol-C9-PEG5-acid / Unkown
HY-138529 Thiol-C9-PEG5 / Unkown
HY-138586S DMT-dC(ac) Phosphoramidite-13C9, 15N3 / Unkown
HY-141547 Nav1.7-IN-8 Inhibitor / Unkown
HY-141878 di-Ellipticine-RIBOTAC / Unkown
HY-141878A di-Ellipticine-RIBOTAC TFA / Unkown
HY-141913S 3-Chlorotyrosine-13C9, 15N hydrochloride / Unkown
HY-143906 URAT1 inhibitor 2 Inhibitor / Unkown
HY-145490 trans-Hydroxy Glimepiride / Unkown
HY-147807 HIV-1 inhibitor-40 Inhibitor / Unkown
HY-148597 FGFR-IN-10 Inhibitor / Unkown
HY-149566 Thalidomide-5-O-C9-NH2 hydrochloride Inducer 99.59% Unkown
HY-149572 Thalidomide-4-O-C9-NH2 hydrochloride Inducer 99.26% Unkown
HY-149866 HIV-1 inhibitor-58 Inhibitor / Unkown
HY-150710S Cytidine 5'-triphosphate-13C9,15N3 ammonium / Unkown
HY-151251 CYP2C9/CYP2C19-IN-1 Inhibitor / Unkown
HY-151253 CYP2C1/CYP2C19-IN-2 Inhibitor / Unkown
HY-153371 50-C2-C9-4tail / Unkown
HY-153970 URAT1 inhibitor 7 Inhibitor 98.01% Unkown
HY-156133 Dihydrospinosyn A aglycone / Unkown
HY-159143 BChE-IN-33 Inhibitor / Unkown
HY-160555 (S,R,S)-AHPC-CO-C9-NH2 / Unkown
HY-160555A (S,R,S)-AHPC-CO-C9-NH2 hydrochloride 98.79% Unkown
HY-163208 VH 032 amide-alkylC9-amine hydrochloride / Unkown
HY-163816 Antiproliferative agent-53-d3 Inhibitor / Unkown
HY-164031A Cloperidone hydrochloride Inhibitor / Unkown
HY-164111 JNK-IN-17 Inhibitor / Unkown
HY-166530S Ticlopidine-d6 hydrochloride Inhibitor / Unkown
HY-166934S Endosulfan-13C9 sulfate / Unkown
HY-167872 Bifeprofen Inhibitor / Unkown
HY-168235 (S,R,S)-AHPC-Me-amide-C9-acid Degrader / Unkown
HY-168277 5-Aminothalidomide-C9-Boc / Unkown
HY-169095 (S,R,S)-AHPC-Me-CO-C9-NH2 / Unkown
HY-171722 Ascr#10 Activator / Unkown
HY-171837 c9,t11,c15-CLNA Activator / Unkown
HY-172897 EGFR/DHFR-IN-2 / Unkown
HY-172902 RNA binder 1 / Unkown
HY-173032 VU6033685 Agonist / Unkown
HY-17356G Fenofibrate (GMP) / Unkown
HY-17356S1 Fenofibrate-d4 / Unkown
HY-175447 GDC-0152-amide-PEG2-acid / Unkown
HY-175887 Pomalidomide-C9-Br / Unkown
HY-175977 BnO-CO-O-C9-O-COOH / Unkown
HY-176737 TGF-β1/Smad-IN-1 Inhibitor / Unkown
HY-176905 Tacedinaline-C9-acid / Unkown
HY-177070 Angexostat Inhibitor / Unkown
HY-178479 IDO1-IN-30 / Unkown
HY-178786 RET-IN-31 Inhibitor / Unkown
HY-179154 α-Glucosidase-IN-101 Inhibitor / Unkown
HY-181321 Thalidomide-4-O-C9-Br / Unkown
HY-181611 Polθ-IN-10 / Unkown
HY-181662 DLK-IN-2 Inhibitor / Unkown
HY-181747 CYP11A1-IN-3 Inhibitor / Unkown
HY-182602 KOSN 1724 Inhibitor / Unkown
HY-182890 Thalidomide-5-NH-C9-acid / Unkown
HY-183017 N-Descyclopropanecarbaldehyde olaparib-CO-C9-NHBoc / Unkown
HY-18341S3 L-Thyroxine-13C9,15N / Unkown
HY-184233 C9S Degrader / Unkown
HY-187080 cGAS-IN-5-CH2-amido-C9-NH2 / Unkown
HY-187136 EZH2-IN-13-CO-C9-COOH / Unkown
HY-79131S1 Fmoc-Phe-OH-13C9,15N 99.33% Unkown
HY-B0113S1 Omeprazole-d3-1 Inhibitor 95.09% Unkown
HY-B0153AS Ticlopidine-d4 hydrochloride Inhibitor / Unkown
HY-B1218S Sulfaphenazole-d4 99.66% Unkown
HY-B1422S 9-Aminoacridine-13C6 Inhibitor / Unkown
HY-D0184S5 2'-Deoxycytidine-13C9 96.8% Unkown
HY-E72098 Human CYP2C9, Reductase+b5 / Unkown
HY-N0043R Ginsenoside Rd (Standard) Inhibitor 99.92% Unkown
HY-N0215S9 L-Phenylalanine-13C9,15N,d8 Antagonist / Unkown
HY-N0893S Tetrahydrocurcumin-d6 / Unkown
HY-N0904R Ginsenoside C-K (Standard) Inhibitor / Unkown
HY-N1201S1 Apigenin-13C / Unkown
HY-P0073S Tyr-Gly-Gly-{Phe-13C9,15N}-Met-OH TFA / Unkown
HY-P5538S EPYFGYSGAFK-13C9,15N3 TFA / Unkown
HY-RS00534 AKR1C1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01759 C9 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01760 C9orf72 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01761 C9orf78 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS03460 CYP2C9 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W009216S4 2'-Deoxycytidine-5'-monophosphate-13C9 dilithium 99.5% Unkown
HY-W011090S ((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-13C9,15N3 sodium / Unkown
HY-W015007S Metyrosine-13C9,15N,d7 Inhibitor / Unkown
HY-W018386AS 3-​Bromo-​L-​tyrosine-13C9,15N TFA / Unkown
HY-W018386S1 3-​Bromo-​L-​tyrosine-13C9 / Unkown
HY-W042357S4 Ac-rC Phosphoramidite-13C9 / Unkown
HY-W042357S6 Ac-rC Phosphoramidite-13C9,15N3 / Unkown
HY-W048482S1 rU Phosphoramidite-13C9,15N2 / Unkown
HY-W048482S2 rU Phosphoramidite-13C9 / Unkown
HY-W127393 N-Nonanoyl-L-homoserine lactone / Unkown
HY-W140208 3-Phenylthiophene Inhibitor / Unkown
HY-W663179 DNDI-VL-2098 Inhibitor / Unkown
HY-W707554 Ticlopidine hydrochloride-d6 / Unkown
HY-W753181 (S)-2-Hydroxy-3-phenylpropanoic acid-13C9 / Unkown
HY-105828A Sulfamethylphenazole sodium Inhibitor / Unkown
HY-105828B Sulfamethylphenazole potassium Inhibitor / Unkown
HY-117925 Personalised postprandial-targeting Inhibitor / Unkown
HY-124209 9-keto Fluprostenol / Unkown
HY-124352S 2-Nonyl-3-hydroxy-4-quinolone-d4 / Unkown
HY-132399S Methsuximide-d5 / Unkown
HY-134999 10-Hydroxywarfarin Inhibitor 99.9% Unkown
HY-150712S Uridine triphosphate-13C9,15N2 dilithium / Unkown
HY-164031 Cloperidone Inhibitor / Unkown
HY-169119 Antifungal agent 114 Inhibitor / Unkown
HY-169735 Aurora A inhibitor 4 Inhibitor / Unkown
HY-170367 Antimicrobial agent-35 Inhibitor / Unkown
HY-172335 C9-200 / Unkown
HY-17356S2 Fenofibrate-13C6 / Unkown
HY-175169 Urease-IN-21 Inhibitor / Unkown
HY-178479A (Rac)-IDO1-IN-30 / Unkown
HY-180227 URAT1-IN-15 Inhibitor / Unkown
HY-180273 Antibacterial agent 309 Inhibitor / Unkown
HY-182965 Glucocorticoid receptor antagonist-1 / Unkown
HY-182976 Tenovin-3-CO-C9-NH2 / Unkown
HY-184843 4-Methoxywarfarin Inhibitor / Unkown
HY-184883 VU6035406 Inhibitor / Unkown
HY-76520S Sitaxsentan-13C6 / Unkown
HY-B0113S2 Omeprazole sulfone (methoxy-d3) Inhibitor 99.70% Unkown
HY-B0113S4 Omeprazole-d3 sodium Inhibitor / Unkown
HY-B0113S5 Omeprazole-d6 Inhibitor / Unkown
HY-B0258S1 Gemfibrozil-d6-1 / Unkown
HY-N12962 11S(12R)-EET / Unkown
HY-N12962A 11R(12S)-EET / Unkown
HY-N7482 Pyranocoumarin / Unkown
HY-P0036S3 Octreotide-13C9,15N / Unkown
HY-RS17317 C9 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS20470 Psma4 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS21991 C9orf72 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23772 C9 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W008016S Fmoc-Tyr(tBu)-OH-13C9,15N 98.8% Unkown
HY-W009162S1 Cytidine 5′-monophosphate-13C9 dilithium / Unkown
HY-W413619 Cipargamin enantiomer Inhibitor / Unkown
HY-W440809 Nonyl 8-bromooctanoate / Unkown
HY-W739842 8-Hydroxywarfarin Inhibitor / Unkown
HY-W753927 9(Z)​,​12(E)​-​Octadecadienoic Acid / Unkown
HY-W800740 Nonyl 6-bromohexanoate / Unkown
HY-113623 Pyrenophorol / Unkown
Inhibitory Antibodies (3)
Art. -Nr. Produktname
Wirkung
Reinheit
Rare Diseases
HY-P99141 Anti-Mouse LAG-3 Antibody (C9B7W) Inhibitor 99% Unkown
HY-P990140 Anti-Rat β-2-Microglobulin Antibody (4C9) / Unkown
HY-P990204 Anti-Mouse LAG-3 (D265A) Antibody (C9B7W) Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Mus musculus C9 MGD MGI:1098282
Felis catus C9 VGNC VGNC:60238
Macaca mulatta C9 VGNC VGNC:70482
Rattus norvegicus C9 RGD RGD:620319
Bos taurus C9 VGNC VGNC:26647
Canis familiaris C9 VGNC VGNC:38603
Others C9 NCBI